Study Summary
This trial is testing whether adding dapagliflozin to semaglutide and insulin improves glycemic control in patients with type 1 diabetes compared to semaglutide and insulin or insulin only treatment.
- Type 1 Diabetes
Treatment Effectiveness
Study Objectives
0 Primary · 13 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
Control
1 of 4
Dual Therapy
1 of 4
Triple therapy
1 of 4
Triple therapy control
1 of 4
Active Control
Experimental Treatment
Non-Treatment Group
114 Total Participants · 4 Treatment Groups
Primary Treatment: Semaglutide · Has Placebo Group · Phase 2 & 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this research include seniors as participants?
"In order to be included in this clinical trial, patients must meet the age requirement of being between 18 and 75 years old. There are currently 183 trials underway for individuals younger than 18 and 353 for seniors aged 65 and up." - Anonymous Online Contributor
How many individuals are participating in this research trial?
"Yes, the information on clinicaltrials.gov indicates that this trial is actively looking for patients. The trial was first posted on 5/1/2019 and was most recently updated on 9/10/2022. 114 patients are needed across 1 location." - Anonymous Online Contributor
Are investigators still seeking participants for this experiment?
"That is correct. The listing on clinicaltrials.gov says that this study, which was originally published on May 1st 2019, is still recruiting patients. So far, 114 people have been accepted across 1 centre." - Anonymous Online Contributor
For what reason is Semaglutide typically prescribed?
"In many cases, chronic weight management is treated with Semaglutide. However, this drug can also help patients that are type 1 diabetic and struggling with calorie restriction or lack of exercise." - Anonymous Online Contributor
Are there any prerequisites for participants of this research?
"This study is currently recruiting 114 individuals aged 18-75 that have diabetes and another autoimmune condition. Furthermore, these patients must measure their blood sugar four or more times a day, have a BMI of at least 25 kg/m2, and have C-peptide levels below 0.23 nM." - Anonymous Online Contributor